CM Life Sciences, Inc. Uncategorized Contracts & Agreements

28 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities
CM Life Sciences, Inc.
Health Care Technology
2024
Form of Option Award Agreement under the 2023 Equity Inducement Plan
CM Life Sciences, Inc.
Health Care Technology
NY
2023
GeneDx Holdings Corp. 2023 Equity Inducement Plan
CM Life Sciences, Inc.
Health Care Technology
DE
2023
Letter Agreement, Amendment No. 2 to Sub-Sublease, dated as of March 20, 2023, by and between Icahn School of Medicine at Mount Sinai and the Company
CM Life Sciences, Inc.
Health Care Technology
2023
Amendment No. 1 to
CM Life Sciences, Inc.
Health Care Technology
2023
Amendment No. 1 to BioMe Biospecimen and Data Access Agreement, dated as of January 19, 2023, by and between Icahn School of Medicine at Mount Sinai and Sema4 OpCo, Inc
CM Life Sciences, Inc.
Health Care Technology
2023
Description of Securities
CM Life Sciences, Inc.
Health Care Technology
2023
Amendment No.1 to the
CM Life Sciences, Inc.
Health Care Technology
2022
Executive Chairman Agreement, date
CM Life Sciences, Inc.
Health Care Technology
NY
2022
Description of Securities
CM Life Sciences, Inc.
Health Care Technology
2022
Sub-Sublease, dated as of June 6, 2017, by and between Icahn School of Medicine at Mount Sinai and the Company, as amended July 31, 2019
CM Life Sciences, Inc.
Health Care Technology
2021
Form of Earn-Out RSU Agreement
CM Life Sciences, Inc.
Health Care Technology
DE
2021
Amended and Restated
CM Life Sciences, Inc.
Health Care Technology
NY
2021
Indemnity Agreement, dated September 1, 2020, by and between the Company and Nat Turner
CM Life Sciences, Inc.
Health Care Technology
DE
2021
Indemnity Agreement, dated September 1, 2020, by and between the Company and Emily Leproust
CM Life Sciences, Inc.
Health Care Technology
DE
2021
Indemnity Agreement, dated September 1, 2020, by and between the Company and Munib Islam
CM Life Sciences, Inc.
Health Care Technology
DE
2021
Indemnity Agreement, dated September 1, 2020, by and between the Company and Sean George
CM Life Sciences, Inc.
Health Care Technology
DE
2021
Indemnity Agreement, dated September 1, 2020, by and between the Company and Shaun Rodriguez
CM Life Sciences, Inc.
Health Care Technology
DE
2021
Indemnity Agreement, dated September 1, 2020, by and between the Company and Brian Emes
CM Life Sciences, Inc.
Health Care Technology
DE
2021
Indemnity Agreement, dated September 1, 2020, by and between the Company and Keith Meister
CM Life Sciences, Inc.
Health Care Technology
DE
2021
Indemnity Agreement, dated September 1, 2020, by and between the Company and Eli Casdin
CM Life Sciences, Inc.
Health Care Technology
DE
2021
Description of the Companys securities
CM Life Sciences, Inc.
Health Care Technology
2021
Forfeiture Agreement, dated as of February 9, 2021, by and between CMLS Holdings LLC and Mount Sinai Genomics, Inc. d/b/a Sema4
CM Life Sciences, Inc.
Health Care Technology
2021
Sponsor Support Agreement, dated as of February 9, 2021, by and among CMLS Holdings LLC, CM Life Sciences, Inc. and Mount Sinai Genomics, Inc. d/b/a Sema4
CM Life Sciences, Inc.
Health Care Technology
DE
2021
Letter Agreement, dated September 1, 2020, by and among the Company, its officers, its directors and CMLS Holdings LLC
CM Life Sciences, Inc.
Health Care Technology
2020
Form of Indemnity Agreement
CM Life Sciences, Inc.
Health Care Technology
DE
2020
Form of Letter Agreement among the Registrant, CMLS Holdings LLC and each of the executive officers and directors of the Registrant
CM Life Sciences, Inc.
Health Care Technology
2020
Specimen Unit Certificate
CM Life Sciences, Inc.
Health Care Technology
2020